onco innovations expands manufacturing scale up of its pnkp inhibitor technology with dalton pharma services advancing multi kilogram non gmp synthesis to support ind enabling studies

WB_1614_NUTRITIONAL_PROGRAMSWB_1609_FOOD_AND_IN_KIND_TRANSFERSWB_1615_THERAPEUTICWB_1466_SOCIAL_ASSISTANCE

The full article is on the original publisher site. This page only shows the headline and a very short excerpt.